Upregulation of transmembrane 4 L6 family member 1 predicts poor prognosis in invasive breast cancer-Reference-Cited by-全球学者库

登录注册会员服务联系我们

Upregulation of transmembrane 4 L6 family member 1 predicts poor prognosis in invasive breast cancer

Published:2017-12 Issue:52 Volume:96 Page:e9476
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Xing Peng,Dong Huiting,Liu Qun,Zhao Tingting,Yao Fan,Xu Yingying,Chen Bo,Zheng Xinyu,Wu Yunfei,Jin Feng,Li Jiguang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference18 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial;Hugh;J Clin Oncol,2009

3. Heterogeneity in breast cancer;Polyak;J Clin Invest,2011

4. Triple-negative breast cancer: treatment challenges and solutions;Collignon;Breast Cancer (Dove Med Press,2016

5. TM4SF1 promotes proliferation, invasion, and metastasis in human liver cancer cells;Huang;Int J Mol Sci,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression;Molecular Carcinogenesis;2024-01-22

2. Prognostic significance of TM4SF1 and DDR1 expression in epithelial ovarian cancer;Oncology Letters;2023-08-30

3. Multi-omic lineage tracing predicts the transcriptional, epigenetic and genetic determinants of cancer evolution;2023-06-30

4. TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC;Biology Direct;2023-04-17

5. Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance;Pharmaceuticals;2023-01-11

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前全球学者库共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3